A citation-based method for searching scientific literature

William H Herman, Thomas J Hoerger, Michael Brandle, Katherine Hicks, Stephen Sorensen, Ping Zhang, Richard F Hamman, Ronald T Ackermann, Michael M Engelgau, Robert E Ratner. Ann Intern Med 2005
Times Cited: 457







List of co-cited articles
592 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
55


10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
William C Knowler, Sarah E Fowler, Richard F Hamman, Costas A Christophi, Heather J Hoffman, Anne T Brenneman, Janet O Brown-Friday, Ronald Goldberg, Elizabeth Venditti, David M Nathan. Lancet 2009
24

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, M Laakso, A Louheranta, M Rastas,[...]. N Engl J Med 2001
22






Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.
Jaana Lindström, Pirjo Ilanne-Parikka, Markku Peltonen, Sirkka Aunola, Johan G Eriksson, Katri Hemiö, Helena Hämäläinen, Pirjo Härkönen, Sirkka Keinänen-Kiukaanniemi, Mauri Laakso,[...]. Lancet 2006
14

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
X R Pan, G W Li, Y H Hu, J X Wang, W Y Yang, Z X An, Z X Hu, J Lin, J Z Xiao, H B Cao,[...]. Diabetes Care 1997
13


The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
Guangwei Li, Ping Zhang, Jinping Wang, Edward W Gregg, Wenying Yang, Qiuhong Gong, Hui Li, Hongliang Li, Yayun Jiang, Yali An,[...]. Lancet 2008
955
12

How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?
Mohammed K Ali, Justin Echouffo-Tcheugui, David F Williamson. Health Aff (Millwood) 2012
366
12

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
Guangwei Li, Ping Zhang, Jinping Wang, Yali An, Qiuhong Gong, Edward W Gregg, Wenying Yang, Bo Zhang, Ying Shuai, Jing Hong,[...]. Lancet Diabetes Endocrinol 2014
370
12

Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
David M Eddy, Leonard Schlessinger, Richard Kahn. Ann Intern Med 2005
226
11

The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.
V R Aroda, C A Christophi, S L Edelstein, P Zhang, W H Herman, E Barrett-Connor, L M Delahanty, M G Montez, R T Ackermann, X Zhuo,[...]. J Clin Endocrinol Metab 2015
221
11

A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program.
Elizabeth K Ely, Stephanie M Gruss, Elizabeth T Luman, Edward W Gregg, Mohammed K Ali, Kunthea Nhim, Deborah B Rolka, Ann L Albright. Diabetes Care 2017
165
11

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. Lancet 2002
11

Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
Qiuhong Gong, Ping Zhang, Jinping Wang, Jixiang Ma, Yali An, Yanyan Chen, Bo Zhang, Xinxing Feng, Hui Li, Xiaoping Chen,[...]. Lancet Diabetes Endocrinol 2019
152
11

Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study.
Ronald T Ackermann, Emily A Finch, Edward Brizendine, Honghong Zhou, David G Marrero. Am J Prev Med 2008
424
10

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.
Robert E Ratner, Costas A Christophi, Boyd E Metzger, Dana Dabelea, Peter H Bennett, Xavier Pi-Sunyer, Sarah Fowler, Steven E Kahn. J Clin Endocrinol Metab 2008
489
10

Prediabetes: a high-risk state for diabetes development.
Adam G Tabák, Christian Herder, Wolfgang Rathmann, Eric J Brunner, Mika Kivimäki. Lancet 2012
10



Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
H C Gerstein, S Yusuf, J Bosch, J Pogue, P Sheridan, N Dinccag, M Hanefeld, B Hoogwerf, M Laakso, V Mohan,[...]. Lancet 2006
9

Effectiveness and cost-effectiveness of diabetes prevention among adherent participants.
William H Herman, Sharon L Edelstein, Robert E Ratner, Maria G Montez, Ronald T Ackermann, Trevor J Orchard, Mary A Foulkes, Ping Zhang, Christopher D Saudek, Morton B Brown. Am J Manag Care 2013
63
14


Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
J Sonya Haw, Karla I Galaviz, Audrey N Straus, Alysse J Kowalski, Matthew J Magee, Mary Beth Weber, Jingkai Wei, K M Venkat Narayan, Mohammed K Ali. JAMA Intern Med 2017
141
9


Effect of weight loss with lifestyle intervention on risk of diabetes.
Richard F Hamman, Rena R Wing, Sharon L Edelstein, John M Lachin, George A Bray, Linda Delahanty, Mary Hoskin, Andrea M Kriska, Elizabeth J Mayer-Davis, Xavier Pi-Sunyer,[...]. Diabetes Care 2006
739
9

Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review.
Rui Li, Ping Zhang, Lawrence E Barker, Farah M Chowdhury, Xuanping Zhang. Diabetes Care 2010
280
8




Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.
William H Hernan, Michael Brandle, Ping Zhang, David F Williamson, Margaret J Matulik, Robert E Ratner, John M Lachin, Michael M Engelgau. Diabetes Care 2003
249
8

Cardiometabolic Risk Factor Changes Observed in Diabetes Prevention Programs in US Settings: A Systematic Review and Meta-analysis.
Uma Mudaliar, Azadeh Zabetian, Michael Goodman, Justin B Echouffo-Tcheugui, Ann L Albright, Edward W Gregg, Mohammed K Ali. PLoS Med 2016
79
10

Pioglitazone for diabetes prevention in impaired glucose tolerance.
Ralph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, George A Bray, Thomas A Buchanan, Stephen C Clement, Robert R Henry, Howard N Hodis, Abbas E Kitabchi,[...]. N Engl J Med 2011
474
8

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
Carel W le Roux, Arne Astrup, Ken Fujioka, Frank Greenway, David C W Lau, Luc Van Gaal, Rafael Violante Ortiz, John P H Wilding, Trine V Skjøth, Linda Shapiro Manning,[...]. Lancet 2017
294
8




Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.
Thomas J Hoerger, Katherine A Hicks, Stephen W Sorensen, William H Herman, Robert E Ratner, Ronald T Ackermann, Ping Zhang, Michael M Engelgau. Diabetes Care 2007
80
8



Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.
Ryuzo Kawamori, Naoko Tajima, Yasuhiko Iwamoto, Atsunori Kashiwagi, Kazuaki Shimamoto, Kohei Kaku. Lancet 2009
184
7

Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
Peter J Neumann, Joshua T Cohen, Milton C Weinstein. N Engl J Med 2014
7


Exercise and insulin resistance in youth: a meta-analysis.
Michael V Fedewa, Nicholas H Gist, Ellen M Evans, Rod K Dishman. Pediatrics 2014
85
7

Breaks in sedentary time: beneficial associations with metabolic risk.
Genevieve N Healy, David W Dunstan, Jo Salmon, Ester Cerin, Jonathan E Shaw, Paul Z Zimmet, Neville Owen. Diabetes Care 2008
930
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.